OncXerna Therapeutics Employee Directory
Biotechnology ResearchMassachusetts, United States11-50 Employees
OncXerna Therapeutics is a clinical-stage biotechnology company focused on precision medicine for oncology. It develops therapies for solid tumors and utilizes an RNA expression-based biomarker approach to match a patient’s tumor with the most appropriate drug, aiming to accelerate development, regulatory approval, and eventual commercialization. The company’s lead candidate, navicixizumab, targets DLL4 and VEGF and is being studied in ovarian cancer, triple-negative breast cancer, and colorectal cancer, while another candidate, bavituximab, is in Phase 2 trials to counter tumor immune suppression. These programs are supported by ongoing collaborations and a broader platform that integrates biomarker data with clinical development expertise to inform treatment strategies.